Recent Advances and Future Perspective of DC-Based Therapy in NSCLC

Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since therapy is only effective in a minority of patients and does not always induce a long-lasting response. This highlights the importance of exploring new treatment options. The clinical success of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Hoorn, Iris A. E., Flórez-Grau, Georgina, van den Heuvel, Michel M., de Vries, I. Jolanda M., Piet, Berber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273436/
https://www.ncbi.nlm.nih.gov/pubmed/34262573
http://dx.doi.org/10.3389/fimmu.2021.704776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273436/
https://www.ncbi.nlm.nih.gov/pubmed/34262573
http://dx.doi.org/10.3389/fimmu.2021.704776

Ejemplares similares